NCT01637961 · OUTCOME
Number of Participants With Adverse Events as Assessed by NCI CTCAE Version 4.0
Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus · Source last updated 2019-07-23
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- Every cycle during treatment and 30 days after the last treatment, up to 5 years.
Analysis population: Eligible and treated patients
Groups in this outcome
Grade 0
Number of patients who did not experience the specified AE.
Grade 1 (CTCAE v 4.0)
Number of patients who experienced a grade 1 event using Common Terminology Criteria version 4.0
Grade 2 (CTCAE v 4.0)
Number of patients who experienced a grade 2 event using Common Terminology Criteria version 4.0
Grade 3 (CTCAE v 4.0)
Number of patients who experienced a grade 3 event using Common Terminology Criteria version 4.0
Grade 4 (CTCAE v 4.0)
Number of patients who experienced a grade 4 event using Common Terminology Criteria version 4.0
Grade 5 (CTCAE v 4.0)
Number of patients who experienced a grade 5 event using Common Terminology Criteria version 4.0
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
| Group | Source count |
|---|
| Grade 0 | 21 |
|---|
| Grade 1 (CTCAE v 4.0) | 21 |
|---|
| Grade 2 (CTCAE v 4.0) | 21 |
|---|
| Grade 3 (CTCAE v 4.0) | 21 |
|---|
| Grade 4 (CTCAE v 4.0) | 21 |
|---|
| Grade 5 (CTCAE v 4.0) | 21 |
|---|
Reported measurements
Leukopenia
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 9 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 5 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Thrombocytopenia
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 11 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 9 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Neutropenia
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 11 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 5 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Anemia
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 5 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 9 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Other investigations
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 18 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Other blood/lymphatics
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 19 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Cardiac
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 20 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Nausea
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 15 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Vomiting
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 18 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Other gastrointestinal
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 7 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 6 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
General and administration site
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 9 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 5 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 7 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Infections/infestations
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 19 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Metabolism/nutrition
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 14 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 6 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Musculoskeletal/connective tissue
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 16 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Peripheral sensory neuropathy
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 20 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Nervous system
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 12 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 5 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Psychiatric
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 19 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Renal/urinary
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 19 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Reproductive/breast
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 19 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Respiratory/thoracic/mediastinal
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 16 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Skin/subcutaneous
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 7 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 5 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 7 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Vascular disorders
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 19 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 4.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 4.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 9
- group Id
- OG001
- value
- 3
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 5
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Leukopenia
- categories
- measurements
- group Id
- OG000
- value
- 11
- group Id
- OG001
- value
- 9
- group Id
- OG002
- value
- 0
- group Id
- OG003
- value
- 1
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Thrombocytopenia
- categories
- measurements
- group Id
- OG000
- value
- 11
- group Id
- OG001
- value
- 0
- group Id
- OG002
- value
- 3
- group Id
- OG003
- value
- 5
- group Id
- OG004
- value
- 2
- group Id
- OG005
- value
- 0
- title
- Neutropenia
- categories
- measurements
- group Id
- OG000
- value
- 5
- group Id
- OG001
- value
- 3
- group Id
- OG002
- value
- 9
- group Id
- OG003
- value
- 3
- group Id
- OG004
- value
- 1
- group Id
- OG005
- value
- 0
- title
- Anemia
- categories
- measurements
- group Id
- OG000
- value
- 18
- group Id
- OG001
- value
- 3
- group Id
- OG002
- value
- 0
- group Id
- OG003
- value
- 0
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Other investigations
- categories
- measurements
- group Id
- OG000
- value
- 19
- group Id
- OG001
- value
- 0
- group Id
- OG002
- value
- 0
- group Id
- OG003
- value
- 1
- group Id
- OG004
- value
- 1
- group Id
- OG005
- value
- 0
- title
- Other blood/lymphatics
- categories
- measurements
- group Id
- OG000
- value
- 20
- group Id
- OG001
- value
- 0
- group Id
- OG002
- value
- 0
- group Id
- OG003
- value
- 1
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Cardiac
- categories
- measurements
- group Id
- OG000
- value
- 15
- group Id
- OG001
- value
- 3
- group Id
- OG002
- value
- 3
- group Id
- OG003
- value
- 0
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Nausea
- categories
- measurements
- group Id
- OG000
- value
- 18
- group Id
- OG001
- value
- 3
- group Id
- OG002
- value
- 0
- group Id
- OG003
- value
- 0
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Vomiting
- categories
- measurements
- group Id
- OG000
- value
- 4
- group Id
- OG001
- value
- 7
- group Id
- OG002
- value
- 6
- group Id
- OG003
- value
- 4
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Other gastrointestinal
- categories
- measurements
- group Id
- OG000
- value
- 9
- group Id
- OG001
- value
- 5
- group Id
- OG002
- value
- 7
- group Id
- OG003
- value
- 0
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- General and administration site
- categories
- measurements
- group Id
- OG000
- value
- 19
- group Id
- OG001
- value
- 0
- group Id
- OG002
- value
- 2
- group Id
- OG003
- value
- 0
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Infections/infestations
- denoms
- counts
- group Id
- OG000
- value
- 21
- group Id
- OG001
- value
- 21
- group Id
- OG002
- value
- 21
- group Id
- OG003
- value
- 21
- group Id
- OG004
- value
- 21
- group Id
- OG005
- value
- 21
- units
- Participants
- groups
- description
- Number of patients who did not experience the specified AE.
- id
- OG000
- title
- Grade 0
- description
- Number of patients who experienced a grade 1 event using Common Terminology Criteria version 4.0
- id
- OG001
- title
- Grade 1 (CTCAE v 4.0)
- description
- Number of patients who experienced a grade 2 event using Common Terminology Criteria version 4.0
- id
- OG002
- title
- Grade 2 (CTCAE v 4.0)
- description
- Number of patients who experienced a grade 3 event using Common Terminology Criteria version 4.0
- id
- OG003
- title
- Grade 3 (CTCAE v 4.0)
- description
- Number of patients who experienced a grade 4 event using Common Terminology Criteria version 4.0
- id
- OG004
- title
- Grade 4 (CTCAE v 4.0)
- description
- Number of patients who experienced a grade 5 event using Common Terminology Criteria version 4.0
- id
- OG005
- title
- Grade 5 (CTCAE v 4.0)
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Eligible and treated patients
- reporting Status
- POSTED
- time Frame
- Every cycle during treatment and 30 days after the last treatment, up to 5 years.
- title
- Number of Participants With Adverse Events as Assessed by NCI CTCAE Version 4.0
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle